Free Trial

Warby Parker (WRBY) Competitors

Warby Parker logo
$22.42 +1.05 (+4.91%)
Closing price 07/8/2025 03:59 PM Eastern
Extended Trading
$22.38 -0.04 (-0.16%)
As of 07/8/2025 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

WRBY vs. STVN, GKOS, IRTC, NARI, TMDX, BLCO, SLNO, INSP, NVST, and PRCT

Should you be buying Warby Parker stock or one of its competitors? The main competitors of Warby Parker include Stevanato Group (STVN), Glaukos (GKOS), iRhythm Technologies (IRTC), Inari Medical (NARI), TransMedics Group (TMDX), Bausch + Lomb (BLCO), Soleno Therapeutics (SLNO), Inspire Medical Systems (INSP), Envista (NVST), and PROCEPT BioRobotics (PRCT). These companies are all part of the "medical equipment" industry.

Warby Parker vs. Its Competitors

Stevanato Group (NYSE:STVN) and Warby Parker (NYSE:WRBY) are both mid-cap medical equipment companies, but which is the superior business? We will contrast the two businesses based on the strength of their media sentiment, earnings, dividends, profitability, institutional ownership, risk, analyst recommendations and valuation.

Stevanato Group has higher revenue and earnings than Warby Parker. Warby Parker is trading at a lower price-to-earnings ratio than Stevanato Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Stevanato Group€1.19B6.34€127.45M€0.5149.08
Warby Parker$771.32M3.04-$20.39M-$0.12-186.83

In the previous week, Warby Parker had 1 more articles in the media than Stevanato Group. MarketBeat recorded 4 mentions for Warby Parker and 3 mentions for Stevanato Group. Stevanato Group's average media sentiment score of 1.30 beat Warby Parker's score of 0.78 indicating that Stevanato Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Stevanato Group
3 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Warby Parker
1 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Warby Parker has a consensus target price of $22.88, suggesting a potential upside of 2.03%. Given Warby Parker's higher probable upside, analysts plainly believe Warby Parker is more favorable than Stevanato Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Stevanato Group
0 Sell rating(s)
2 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
2.86
Warby Parker
0 Sell rating(s)
7 Hold rating(s)
11 Buy rating(s)
0 Strong Buy rating(s)
2.61

93.2% of Warby Parker shares are owned by institutional investors. 18.2% of Warby Parker shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Stevanato Group has a net margin of 11.14% compared to Warby Parker's net margin of -1.79%. Stevanato Group's return on equity of 10.00% beat Warby Parker's return on equity.

Company Net Margins Return on Equity Return on Assets
Stevanato Group11.14% 10.00% 6.03%
Warby Parker -1.79%-2.48%-1.29%

Stevanato Group has a beta of 0.55, suggesting that its stock price is 45% less volatile than the S&P 500. Comparatively, Warby Parker has a beta of 2.09, suggesting that its stock price is 109% more volatile than the S&P 500.

Summary

Stevanato Group beats Warby Parker on 11 of the 17 factors compared between the two stocks.

Get Warby Parker News Delivered to You Automatically

Sign up to receive the latest news and ratings for WRBY and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding WRBY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

WRBY vs. The Competition

MetricWarby ParkerCONS PD IndustryStaples SectorNYSE Exchange
Market Cap$2.23B$33.75B$16.33B$20.52B
Dividend YieldN/A2.71%3.14%3.78%
P/E Ratio-186.8332.2619.9227.79
Price / Sales3.041.8656.9540.41
Price / Cash62.9516.2714.6922.26
Price / Book6.698.816.144.58
Net Income-$20.39M$1.19B$680.31M$982.91M
7 Day Performance2.09%-0.58%-0.82%0.41%
1 Month Performance-0.24%1.01%-0.65%3.59%
1 Year Performance42.62%37.04%7.52%14.47%

Warby Parker Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
WRBY
Warby Parker
1.9659 of 5 stars
$22.42
+4.9%
$22.88
+2.0%
+45.0%$2.23B$771.32M-186.833,780
STVN
Stevanato Group
N/A€24.51
-0.5%
N/A+35.0%€7.42B€1.19B48.065,521
GKOS
Glaukos
4.5576 of 5 stars
$103.42
+2.0%
$134.67
+30.2%
-16.3%$5.80B$383.48M-43.64780Positive News
IRTC
iRhythm Technologies
1.0383 of 5 stars
$153.96
-0.5%
$138.60
-10.0%
+40.4%$4.94B$591.84M-49.032,000
NARI
Inari Medical
N/A$79.97
flat
$69.22
-13.4%
N/A$4.68B$493.63M-59.24800
TMDX
TransMedics Group
1.6918 of 5 stars
$134.01
+1.9%
$127.33
-5.0%
-16.4%$4.45B$441.54M98.54210
BLCO
Bausch + Lomb
2.9359 of 5 stars
$13.03
+5.1%
$15.54
+19.3%
-8.2%$4.39B$4.79B25.8313,500Analyst Forecast
High Trading Volume
SLNO
Soleno Therapeutics
4.7672 of 5 stars
$83.78
+0.6%
$107.10
+27.8%
+101.0%$4.20BN/A-18.1330
INSP
Inspire Medical Systems
4.8288 of 5 stars
$129.28
-2.4%
$211.91
+63.9%
-1.7%$3.91B$802.80M59.581,246News Coverage
Positive News
NVST
Envista
3.8167 of 5 stars
$19.58
-0.5%
$20.23
+3.3%
+22.8%$3.33B$2.51B-3.0012,300
PRCT
PROCEPT BioRobotics
2.6677 of 5 stars
$57.60
+1.2%
$90.00
+56.3%
-9.8%$3.15B$224.50M-33.88430Analyst Forecast

Related Companies and Tools


This page (NYSE:WRBY) was last updated on 7/9/2025 by MarketBeat.com Staff
From Our Partners